Global Antibody-drug Conjugates Sales Market Report 2017

Publisher Name :
Date: 22-Dec-2017
No. of pages: 104
Inquire Before Buying

In this report, the global Antibody-drug Conjugates market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Antibody-drug Conjugates for these regions, from 2012 to 2022 (forecast), covering

- United States

- China

- Europe

- Japan

- Southeast Asia

- India

Global Antibody-drug Conjugates market competition by top manufacturers/players, with Antibody-drug Conjugates sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

- ImmunoGen

- Seattle Genetics

- Roche

- Takeda

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

- Adcetris

- Kadcyla

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

- Breast Cancer

- Lymphoma

If you have any special requirements, please let us know and we will offer you the report as you want.

Global Antibody-drug Conjugates Sales Market Report 2017

Table of Contents
Global Antibody-drug Conjugates Sales Market Report 2017
1 Antibody-drug Conjugates Market Overview
1.1 Product Overview and Scope of Antibody-drug Conjugates
1.2 Classification of Antibody-drug Conjugates by Product Category
1.2.1 Global Antibody-drug Conjugates Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Antibody-drug Conjugates Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Adcetris
1.2.4 Kadcyla
1.3 Global Antibody-drug Conjugates Market by Application/End Users
1.3.1 Global Antibody-drug Conjugates Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Breast Cancer
1.3.3 Lymphoma
1.4 Global Antibody-drug Conjugates Market by Region
1.4.1 Global Antibody-drug Conjugates Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.3 China Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.4 Europe Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.5 Japan Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.6 Southeast Asia Antibody-drug Conjugates Status and Prospect (2012-2022)
1.4.7 India Antibody-drug Conjugates Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Antibody-drug Conjugates (2012-2022)
1.5.1 Global Antibody-drug Conjugates Sales and Growth Rate (2012-2022)
1.5.2 Global Antibody-drug Conjugates Revenue and Growth Rate (2012-2022)
2 Global Antibody-drug Conjugates Competition by Players/Suppliers, Type and Application
2.1 Global Antibody-drug Conjugates Market Competition by Players/Suppliers
2.1.1 Global Antibody-drug Conjugates Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Antibody-drug Conjugates Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Antibody-drug Conjugates (Volume and Value) by Type
2.2.1 Global Antibody-drug Conjugates Sales and Market Share by Type (2012-2017)
2.2.2 Global Antibody-drug Conjugates Revenue and Market Share by Type (2012-2017)
2.3 Global Antibody-drug Conjugates (Volume and Value) by Region
2.3.1 Global Antibody-drug Conjugates Sales and Market Share by Region (2012-2017)
2.3.2 Global Antibody-drug Conjugates Revenue and Market Share by Region (2012-2017)
2.4 Global Antibody-drug Conjugates (Volume) by Application
3 United States Antibody-drug Conjugates (Volume, Value and Sales Price)
3.1 United States Antibody-drug Conjugates Sales and Value (2012-2017)
3.1.1 United States Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
3.1.2 United States Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
3.1.3 United States Antibody-drug Conjugates Sales Price Trend (2012-2017)
3.2 United States Antibody-drug Conjugates Sales Volume and Market Share by Players
3.3 United States Antibody-drug Conjugates Sales Volume and Market Share by Type
3.4 United States Antibody-drug Conjugates Sales Volume and Market Share by Application
4 China Antibody-drug Conjugates (Volume, Value and Sales Price)
4.1 China Antibody-drug Conjugates Sales and Value (2012-2017)
4.1.1 China Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
4.1.2 China Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
4.1.3 China Antibody-drug Conjugates Sales Price Trend (2012-2017)
4.2 China Antibody-drug Conjugates Sales Volume and Market Share by Players
4.3 China Antibody-drug Conjugates Sales Volume and Market Share by Type
4.4 China Antibody-drug Conjugates Sales Volume and Market Share by Application
5 Europe Antibody-drug Conjugates (Volume, Value and Sales Price)
5.1 Europe Antibody-drug Conjugates Sales and Value (2012-2017)
5.1.1 Europe Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
5.1.2 Europe Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
5.1.3 Europe Antibody-drug Conjugates Sales Price Trend (2012-2017)
5.2 Europe Antibody-drug Conjugates Sales Volume and Market Share by Players
5.3 Europe Antibody-drug Conjugates Sales Volume and Market Share by Type
5.4 Europe Antibody-drug Conjugates Sales Volume and Market Share by Application
6 Japan Antibody-drug Conjugates (Volume, Value and Sales Price)
6.1 Japan Antibody-drug Conjugates Sales and Value (2012-2017)
6.1.1 Japan Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
6.1.2 Japan Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
6.1.3 Japan Antibody-drug Conjugates Sales Price Trend (2012-2017)
6.2 Japan Antibody-drug Conjugates Sales Volume and Market Share by Players
6.3 Japan Antibody-drug Conjugates Sales Volume and Market Share by Type
6.4 Japan Antibody-drug Conjugates Sales Volume and Market Share by Application
7 Southeast Asia Antibody-drug Conjugates (Volume, Value and Sales Price)
7.1 Southeast Asia Antibody-drug Conjugates Sales and Value (2012-2017)
7.1.1 Southeast Asia Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Antibody-drug Conjugates Sales Price Trend (2012-2017)
7.2 Southeast Asia Antibody-drug Conjugates Sales Volume and Market Share by Players
7.3 Southeast Asia Antibody-drug Conjugates Sales Volume and Market Share by Type
7.4 Southeast Asia Antibody-drug Conjugates Sales Volume and Market Share by Application
8 India Antibody-drug Conjugates (Volume, Value and Sales Price)
8.1 India Antibody-drug Conjugates Sales and Value (2012-2017)
8.1.1 India Antibody-drug Conjugates Sales and Growth Rate (2012-2017)
8.1.2 India Antibody-drug Conjugates Revenue and Growth Rate (2012-2017)
8.1.3 India Antibody-drug Conjugates Sales Price Trend (2012-2017)
8.2 India Antibody-drug Conjugates Sales Volume and Market Share by Players
8.3 India Antibody-drug Conjugates Sales Volume and Market Share by Type
8.4 India Antibody-drug Conjugates Sales Volume and Market Share by Application
9 Global Antibody-drug Conjugates Players/Suppliers Profiles and Sales Data
9.1 ImmunoGen
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Antibody-drug Conjugates Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 ImmunoGen Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Seattle Genetics
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Antibody-drug Conjugates Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Seattle Genetics Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Roche
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Antibody-drug Conjugates Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Roche Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Takeda
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Antibody-drug Conjugates Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Takeda Antibody-drug Conjugates Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
10 Antibody-drug Conjugates Maufacturing Cost Analysis
10.1 Antibody-drug Conjugates Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Antibody-drug Conjugates
10.3 Manufacturing Process Analysis of Antibody-drug Conjugates
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Antibody-drug Conjugates Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Antibody-drug Conjugates Major Manufacturers in 2016
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Antibody-drug Conjugates Market Forecast (2017-2022)
14.1 Global Antibody-drug Conjugates Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Antibody-drug Conjugates Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Antibody-drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Antibody-drug Conjugates Price and Trend Forecast (2017-2022)
14.2 Global Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Antibody-drug Conjugates Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Antibody-drug Conjugates Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Antibody-drug Conjugates Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Antibody-drug Conjugates Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Antibody-drug Conjugates Sales Forecast by Type (2017-2022)
14.3.2 Global Antibody-drug Conjugates Revenue Forecast by Type (2017-2022)
14.3.3 Global Antibody-drug Conjugates Price Forecast by Type (2017-2022)
14.4 Global Antibody-drug Conjugates Sales Volume Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Antibody-drug Conjugates
Figure Global Antibody-drug Conjugates Sales Volume Comparison (K Pcs) by Type (2012-2022)
Figure Global Antibody-drug Conjugates Sales Volume Market Share by Type (Product Category) in 2016
Figure Adcetris Product Picture
Figure Kadcyla Product Picture
Figure Global Antibody-drug Conjugates Sales Comparison (K Pcs) by Application (2012-2022)
Figure Global Sales Market Share of Antibody-drug Conjugates by Application in 2016
Figure Breast Cancer Examples
Table Key Downstream Customer in Breast Cancer
Figure Lymphoma Examples
Table Key Downstream Customer in Lymphoma
Figure Global Antibody-drug Conjugates Market Size (Million USD) by Regions (2012-2022)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Antibody-drug Conjugates Sales Volume (K Pcs) and Growth Rate (2012-2022)
Figure Global Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Market Major Players Antibody-drug Conjugates Sales Volume (K Pcs) (2012-2017)
Table Global Antibody-drug Conjugates Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table Global Antibody-drug Conjugates Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Antibody-drug Conjugates Sales Share by Players/Suppliers
Figure 2017 Antibody-drug Conjugates Sales Share by Players/Suppliers
Figure Global Antibody-drug Conjugates Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Antibody-drug Conjugates Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Global Antibody-drug Conjugates Revenue Share by Players/Suppliers (2012-2017)
Table 2016 Global Antibody-drug Conjugates Revenue Share by Players
Table 2017 Global Antibody-drug Conjugates Revenue Share by Players
Table Global Antibody-drug Conjugates Sales (K Pcs) and Market Share by Type (2012-2017)
Table Global Antibody-drug Conjugates Sales Share (K Pcs) by Type (2012-2017)
Figure Sales Market Share of Antibody-drug Conjugates by Type (2012-2017)
Figure Global Antibody-drug Conjugates Sales Growth Rate by Type (2012-2017)
Table Global Antibody-drug Conjugates Revenue (Million USD) and Market Share by Type (2012-2017)
Table Global Antibody-drug Conjugates Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antibody-drug Conjugates by Type (2012-2017)
Figure Global Antibody-drug Conjugates Revenue Growth Rate by Type (2012-2017)
Table Global Antibody-drug Conjugates Sales Volume (K Pcs) and Market Share by Region (2012-2017)
Table Global Antibody-drug Conjugates Sales Share by Region (2012-2017)
Figure Sales Market Share of Antibody-drug Conjugates by Region (2012-2017)
Figure Global Antibody-drug Conjugates Sales Growth Rate by Region in 2016
Table Global Antibody-drug Conjugates Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Antibody-drug Conjugates Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Antibody-drug Conjugates by Region (2012-2017)
Figure Global Antibody-drug Conjugates Revenue Growth Rate by Region in 2016
Table Global Antibody-drug Conjugates Revenue (Million USD) and Market Share by Region (2012-2017)
Table Global Antibody-drug Conjugates Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Antibody-drug Conjugates by Region (2012-2017)
Figure Global Antibody-drug Conjugates Revenue Market Share by Region in 2016
Table Global Antibody-drug Conjugates Sales Volume (K Pcs) and Market Share by Application (2012-2017)
Table Global Antibody-drug Conjugates Sales Share (%) by Application (2012-2017)
Figure Sales Market Share of Antibody-drug Conjugates by Application (2012-2017)
Figure Global Antibody-drug Conjugates Sales Market Share by Application (2012-2017)
Figure United States Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (2012-2017)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure United States Antibody-drug Conjugates Sales Price (USD/Pcs) Trend (2012-2017)
Table United States Antibody-drug Conjugates Sales Volume (K Pcs) by Players (2012-2017)
Table United States Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure United States Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table United States Antibody-drug Conjugates Sales Volume (K Pcs) by Type (2012-2017)
Table United States Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure United States Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table United States Antibody-drug Conjugates Sales Volume (K Pcs) by Application (2012-2017)
Table United States Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure United States Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Figure China Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (2012-2017)
Figure China Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Antibody-drug Conjugates Sales Price (USD/Pcs) Trend (2012-2017)
Table China Antibody-drug Conjugates Sales Volume (K Pcs) by Players (2012-2017)
Table China Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure China Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table China Antibody-drug Conjugates Sales Volume (K Pcs) by Type (2012-2017)
Table China Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure China Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table China Antibody-drug Conjugates Sales Volume (K Pcs) by Application (2012-2017)
Table China Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure China Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Figure Europe Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure Europe Antibody-drug Conjugates Sales Price (USD/Pcs) Trend (2012-2017)
Table Europe Antibody-drug Conjugates Sales Volume (K Pcs) by Players (2012-2017)
Table Europe Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure Europe Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table Europe Antibody-drug Conjugates Sales Volume (K Pcs) by Type (2012-2017)
Table Europe Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure Europe Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table Europe Antibody-drug Conjugates Sales Volume (K Pcs) by Application (2012-2017)
Table Europe Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure Europe Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Figure Japan Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (2012-2017)
Figure Japan Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Antibody-drug Conjugates Sales Price (USD/Pcs) Trend (2012-2017)
Table Japan Antibody-drug Conjugates Sales Volume (K Pcs) by Players (2012-2017)
Table Japan Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure Japan Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table Japan Antibody-drug Conjugates Sales Volume (K Pcs) by Type (2012-2017)
Table Japan Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure Japan Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table Japan Antibody-drug Conjugates Sales Volume (K Pcs) by Application (2012-2017)
Table Japan Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure Japan Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Figure Southeast Asia Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (2012-2017)
Figure Southeast Asia Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Antibody-drug Conjugates Sales Price (USD/Pcs) Trend (2012-2017)
Table Southeast Asia Antibody-drug Conjugates Sales Volume (K Pcs) by Players (2012-2017)
Table Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table Southeast Asia Antibody-drug Conjugates Sales Volume (K Pcs) by Type (2012-2017)
Table Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table Southeast Asia Antibody-drug Conjugates Sales Volume (K Pcs) by Application (2012-2017)
Table Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Figure India Antibody-drug Conjugates Sales (K Pcs) and Growth Rate (2012-2017)
Figure India Antibody-drug Conjugates Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Antibody-drug Conjugates Sales Price (USD/Pcs) Trend (2012-2017)
Table India Antibody-drug Conjugates Sales Volume (K Pcs) by Players (2012-2017)
Table India Antibody-drug Conjugates Sales Volume Market Share by Players (2012-2017)
Figure India Antibody-drug Conjugates Sales Volume Market Share by Players in 2016
Table India Antibody-drug Conjugates Sales Volume (K Pcs) by Type (2012-2017)
Table India Antibody-drug Conjugates Sales Volume Market Share by Type (2012-2017)
Figure India Antibody-drug Conjugates Sales Volume Market Share by Type in 2016
Table India Antibody-drug Conjugates Sales Volume (K Pcs) by Application (2012-2017)
Table India Antibody-drug Conjugates Sales Volume Market Share by Application (2012-2017)
Figure India Antibody-drug Conjugates Sales Volume Market Share by Application in 2016
Table ImmunoGen Basic Information List
Table ImmunoGen Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure ImmunoGen Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure ImmunoGen Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure ImmunoGen Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Seattle Genetics Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Seattle Genetics Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure Seattle Genetics Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Roche Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Roche Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure Roche Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table Takeda Basic Information List
Table Takeda Antibody-drug Conjugates Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Takeda Antibody-drug Conjugates Sales Growth Rate (2012-2017)
Figure Takeda Antibody-drug Conjugates Sales Global Market Share (2012-2017
Figure Takeda Antibody-drug Conjugates Revenue Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antibody-drug Conjugates
Figure Manufacturing Process Analysis of Antibody-drug Conjugates
Figure Antibody-drug Conjugates Industrial Chain Analysis
Table Raw Materials Sources of Antibody-drug Conjugates Major Players in 2016
Table Major Buyers of Antibody-drug Conjugates
Table Distributors/Traders List
Figure Global Antibody-drug Conjugates Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Global Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Global Antibody-drug Conjugates Price (USD/Pcs) and Trend Forecast (2017-2022)
Table Global Antibody-drug Conjugates Sales Volume (K Pcs) Forecast by Regions (2017-2022)
Figure Global Antibody-drug Conjugates Sales Volume Market Share Forecast by Regions (2017-2022)
Figure Global Antibody-drug Conjugates Sales Volume Market Share Forecast by Regions in 2022
Table Global Antibody-drug Conjugates Revenue (Million USD) Forecast by Regions (2017-2022)
Figure Global Antibody-drug Conjugates Revenue Market Share Forecast by Regions (2017-2022)
Figure Global Antibody-drug Conjugates Revenue Market Share Forecast by Regions in 2022
Figure United States Antibody-drug Conjugates Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure China Antibody-drug Conjugates Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure China Antibody-drug Conjugates Revenue and Growth Rate Forecast (2017-2022)
Figure Europe Antibody-drug Conjugates Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Europe Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Antibody-drug Conjugates Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Japan Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Antibody-drug Conjugates Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Antibody-drug Conjugates Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure India Antibody-drug Conjugates Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Global Antibody-drug Conjugates Sales (K Pcs) Forecast by Type (2017-2022)
Figure Global Antibody-drug Conjugates Sales Volume Market Share Forecast by Type (2017-2022)
Table Global Antibody-drug Conjugates Revenue (Million USD) Forecast by Type (2017-2022)
Figure Global Antibody-drug Conjugates Revenue Market Share Forecast by Type (2017-2022)
Table Global Antibody-drug Conjugates Price (USD/Pcs) Forecast by Type (2017-2022)
Table Global Antibody-drug Conjugates Sales (K Pcs) Forecast by Application (2017-2022)
Figure Global Antibody-drug Conjugates Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Pizotifen Market Research Report 2018
    Published: 18-Jul-2018        Price: US 2900 Onwards        Pages: 99
    This report studies the global Pizotifen market status and forecast, categorizes the global Pizotifen market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa. The global Pizotifen market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The major manufacturer......
  • Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 35
    Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) pipel......
  • Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 37
    Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Pipeline Review, H2 2018 Summary Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) - Transglutaminase 2 (TG2) is a member of the transglutaminase family tha......
  • Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 40
    Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H2 2018 Summary Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Respiratory syncytial virus G protein is a protein produced by respiratory syncytial virus. It attaches the virion to the host cell membrane by interacting with heparan sulfate. It interacts with host CX3CR1, the receptor for the CX3C chemokine fractalkine, to modulate the immune response and facilitate in......
  • Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 70
    Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) - Pipeline Review, H2 2018 Summary Survival Motor Neuron Protein (Component Of Gems 1 or Gemin 1 or SMN1 or SMN2) pipeline Target constitutes close to 15 molecules. Out of which approximately 9 molecules are developed by companies and remaining by the universities/institutes. The latest report Survival Motor Neuron Protein - Pipeline Review, H2 2018, outlays comprehensive information on the S......
  • NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 65
    NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'NT 3 Growth Factor Receptor - Pipeline Review, H2 2018'; NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) pipeline Target constitutes close to 7 molecules. ......
  • MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 41
    MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H2 2018 Summary MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - MAP kinase-interacting serine/threonine-protein kinase 2 is an enzyme encoded by the MKNK2 gene. It phosphorylates SFPQ/PSF, HNRNPA1 and EIF4E. It plays a role in the response to environmental ......
  • BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 129
    BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK2 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'BDNF NT 3 Growth Factors Receptor - Pipeline Review, H2 2018'; BDNF/NT 3 Growth Factors Receptor (GP145 TrkB or Neurotrophic Tyrosine Kinase Receptor Type 2 or TrkB Tyrosine Kinase or Tropomyosin Related Kinase B or NTRK......
  • Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018
    Published: 17-Jul-2018        Price: US 3500 Onwards        Pages: 48
    Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) - Pipeline Review, H2 2018 Summary According to the recently published report 'Ephrin Type B Receptor 4 - Pipeline Review, H2 2018'; Ephrin Type B Receptor 4 (Hepatoma Transmembrane Kinase or Tyrosine Protein Kinase TYRO11 or EPHB4 or EC 2.7.10.1) pipeline Target constitutes close to 6 molecules. Out of which approximately 3 molecules are developed by compa......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs